Skip to content

Bioventus BVS Compensation and benefits

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept bvs:AccruedSalariesAndEmployeeBenefitsCurrent.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's compensation and benefits.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's compensation and benefits?
Bioventus (BVS) reported compensation and benefits of $6.19M in Q1 2026.
How has Bioventus's compensation and benefits changed year-over-year?
Bioventus's compensation and benefits increased by 5.9% year-over-year, from $5.85M to $6.19M.
What is the long-term trend for Bioventus's compensation and benefits?
Over 5 years (2020 to 2025), Bioventus's compensation and benefits has grown at a 2.2% compound annual growth rate (CAGR), from $5.88M to $6.56M.